Acomplia could reach sales of $3 billion per year
Sanofi-Aventis’ new obesity drug Acomplia could eventually generate sales of over $3 billion a year, its chairman told Reuters news ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.